Article Details

Urovant Sciences Ltd (UROV) Receives Consensus Recommendation of “Buy” from Analysts

Retrieved on: 2019-04-06 09:07:30

Tags for this article:

Click the tags to see associated articles and topics

Urovant Sciences Ltd (UROV) Receives Consensus Recommendation of “Buy” from Analysts. View article details on hiswai:

Excerpt

<div>BlackRock Inc. acquired a new stake in Urovant Sciences in the third quarter valued at approximately $4,574,000. Finally, <b>Man Group plc</b> acquired a ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up